Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Towards a standardized bioinformatics infrastructure for N- and O-glycomics.

Rojas-Macias MA, Mariethoz J, Andersson P, Jin C, Venkatakrishnan V, Aoki NP, Shinmachi D, Ashwood C, Madunic K, Zhang T, Miller RL, Horlacher O, Struwe WB, Watanabe Y, Okuda S, Levander F, Kolarich D, Rudd PM, Wuhrer M, Kettner C, Packer NH, Aoki-Kinoshita KF, Lisacek F, Karlsson NG.

Nat Commun. 2019 Jul 22;10(1):3275. doi: 10.1038/s41467-019-11131-x. Review.

2.

The minimum information required for a glycomics experiment (MIRAGE) project: LC guidelines.

Campbell MP, Abrahams JL, Rapp E, Struwe WB, Costello CE, Novotny M, Ranzinger R, York WS, Kolarich D, Rudd PM, Kettner C.

Glycobiology. 2019 May 1;29(5):349-354. doi: 10.1093/glycob/cwz009.

PMID:
30778580
3.

An empirical analysis of enzyme function reporting for experimental reproducibility: Missing/incomplete information in published papers.

Halling P, Fitzpatrick PF, Raushel FM, Rohwer J, Schnell S, Wittig U, Wohlgemuth R, Kettner C.

Biophys Chem. 2018 Nov;242:22-27. doi: 10.1016/j.bpc.2018.08.004. Epub 2018 Aug 24.

4.

A repository for quality-assured data on enzyme activity.

Swainston N, Kettner C.

Nature. 2018 Apr;556(7701):309. doi: 10.1038/d41586-018-04630-2. No abstract available.

PMID:
29670271
5.

STRENDA DB: enabling the validation and sharing of enzyme kinetics data.

Swainston N, Baici A, Bakker BM, Cornish-Bowden A, Fitzpatrick PF, Halling P, Leyh TS, O'Donovan C, Raushel FM, Reschel U, Rohwer JM, Schnell S, Schomburg D, Tipton KF, Tsai MD, Westerhoff HV, Wittig U, Wohlgemuth R, Kettner C.

FEBS J. 2018 Jun;285(12):2193-2204. doi: 10.1111/febs.14427. Epub 2018 Mar 23.

6.

The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting glycan microarray-based data.

Liu Y, McBride R, Stoll M, Palma AS, Silva L, Agravat S, Aoki-Kinoshita KF, Campbell MP, Costello CE, Dell A, Haslam SM, Karlsson NG, Khoo KH, Kolarich D, Novotny MV, Packer NH, Ranzinger R, Rapp E, Rudd PM, Struwe WB, Tiemeyer M, Wells L, York WS, Zaia J, Kettner C, Paulson JC, Feizi T, Smith DF.

Glycobiology. 2017 Apr;27(4):280-284. Epub 2016 Nov 22.

7.

The minimum information required for a glycomics experiment (MIRAGE) project: sample preparation guidelines for reliable reporting of glycomics datasets.

Struwe WB, Agravat S, Aoki-Kinoshita KF, Campbell MP, Costello CE, Dell A, Ten Feizi, Haslam SM, Karlsson NG, Khoo KH, Kolarich D, Liu Y, McBride R, Novotny MV, Packer NH, Paulson JC, Rapp E, Ranzinger R, Rudd PM, Smith DF, Tiemeyer M, Wells L, York WS, Zaia J, Kettner C.

Glycobiology. 2016 Sep;26(9):907-910. Epub 2016 Sep 21.

8.

Meeting new challenges: The 2014 HUPO-PSI/COSMOS Workshop: 13-15 April 2014, Frankfurt, Germany.

Orchard S, Albar JP, Binz PA, Kettner C, Jones AR, Salek RM, Vizcaino JA, Deutsch EW, Hermjakob H.

Proteomics. 2014 Nov;14(21-22):2363-8. doi: 10.1002/pmic.201470164. Epub 2014 Oct 9.

PMID:
25297050
9.

MIRAGE: the minimum information required for a glycomics experiment.

York WS, Agravat S, Aoki-Kinoshita KF, McBride R, Campbell MP, Costello CE, Dell A, Feizi T, Haslam SM, Karlsson N, Khoo KH, Kolarich D, Liu Y, Novotny M, Packer NH, Paulson JC, Rapp E, Ranzinger R, Rudd PM, Smith DF, Struwe WB, Tiemeyer M, Wells L, Zaia J, Kettner C.

Glycobiology. 2014 May;24(5):402-6. doi: 10.1093/glycob/cwu018. Epub 2014 Mar 20.

10.

The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting mass-spectrometry-based glycoanalytic data.

Kolarich D, Rapp E, Struwe WB, Haslam SM, Zaia J, McBride R, Agravat S, Campbell MP, Kato M, Ranzinger R, Kettner C, York WS.

Mol Cell Proteomics. 2013 Apr;12(4):991-5. doi: 10.1074/mcp.O112.026492. Epub 2013 Feb 1.

11.

Meeting Report from the Second "Minimum Information for Biological and Biomedical Investigations" (MIBBI) workshop.

Kettner C, Field D, Sansone SA, Taylor C, Aerts J, Binns N, Blake A, Britten CM, de Marco A, Fostel J, Gaudet P, González-Beltrán A, Hardy N, Hellemans J, Hermjakob H, Juty N, Leebens-Mack J, Maguire E, Neumann S, Orchard S, Parkinson H, Piel W, Ranganathan S, Rocca-Serra P, Santarsiero A, Shotton D, Sterk P, Untergasser A, Whetzel PL.

Stand Genomic Sci. 2010 Dec 25;3(3):259-66. doi: 10.4056/sigs.147362.

12.

A large-scale protein-function database.

Apweiler R, Armstrong R, Bairoch A, Cornish-Bowden A, Halling PJ, Hofmeyr JH, Kettner C, Leyh TS, Rohwer J, Schomburg D, Steinbeck C, Tipton K.

Nat Chem Biol. 2010 Nov;6(11):785. doi: 10.1038/nchembio.460. No abstract available.

13.

[Very severe thrombotic thrombocytopenic purpura (TTP) after H1N1 vaccination].

Hermann R, Pfeil A, Busch M, Kettner C, Kretzschmar D, Hansch A, La Rosée P, Wolf G.

Med Klin (Munich). 2010 Sep;105(9):663-8. doi: 10.1007/s00063-010-1107-6. Epub 2010 Sep 28. German.

PMID:
20878304
14.

BMS-593214, an active site-directed factor VIIa inhibitor: enzyme kinetics, antithrombotic and antihaemostatic studies.

Wong PC, Luettgen JM, Rendina AR, Kettner CA, Xin B, Knabb RM, Wexler R, Priestley ES.

Thromb Haemost. 2010 Aug;104(2):261-9. doi: 10.1160/TH10-01-0025. Epub 2010 Jun 29.

PMID:
20589312
15.

Measuring enzyme activities under standardized in vivo-like conditions for systems biology.

van Eunen K, Bouwman J, Daran-Lapujade P, Postmus J, Canelas AB, Mensonides FI, Orij R, Tuzun I, van den Brink J, Smits GJ, van Gulik WM, Brul S, Heijnen JJ, de Winde JH, de Mattos MJ, Kettner C, Nielsen J, Westerhoff HV, Bakker BM.

FEBS J. 2010 Feb;277(3):749-60. doi: 10.1111/j.1742-4658.2009.07524.x. Epub 2010 Jan 7.

16.

Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project.

Taylor CF, Field D, Sansone SA, Aerts J, Apweiler R, Ashburner M, Ball CA, Binz PA, Bogue M, Booth T, Brazma A, Brinkman RR, Michael Clark A, Deutsch EW, Fiehn O, Fostel J, Ghazal P, Gibson F, Gray T, Grimes G, Hancock JM, Hardy NW, Hermjakob H, Julian RK Jr, Kane M, Kettner C, Kinsinger C, Kolker E, Kuiper M, Le Novère N, Leebens-Mack J, Lewis SE, Lord P, Mallon AM, Marthandan N, Masuya H, McNally R, Mehrle A, Morrison N, Orchard S, Quackenbush J, Reecy JM, Robertson DG, Rocca-Serra P, Rodriguez H, Rosenfelder H, Santoyo-Lopez J, Scheuermann RH, Schober D, Smith B, Snape J, Stoeckert CJ Jr, Tipton K, Sterk P, Untergasser A, Vandesompele J, Wiemann S.

Nat Biotechnol. 2008 Aug;26(8):889-96. doi: 10.1038/nbt.1411. No abstract available.

17.

Good publication practice as a prerequisite for comparable enzyme data?

Kettner C.

In Silico Biol. 2007;7(2 Suppl):S57-64.

PMID:
17822391
18.

1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa.

Pinto DJ, Orwat MJ, Quan ML, Han Q, Galemmo RA Jr, Amparo E, Wells B, Ellis C, He MY, Alexander RS, Rossi KA, Smallwood A, Wong PC, Luettgen JM, Rendina AR, Knabb RM, Mersinger L, Kettner C, Bai S, He K, Wexler RR, Lam PY.

Bioorg Med Chem Lett. 2006 Aug 1;16(15):4141-7. Epub 2006 May 30.

PMID:
16730984
19.

The importance of uniformity in reporting protein-function data.

Apweiler R, Cornish-Bowden A, Hofmeyr JH, Kettner C, Leyh TS, Schomburg D, Tipton K.

Trends Biochem Sci. 2005 Jan;30(1):11-2. No abstract available.

PMID:
15653320
20.

Structural basis for differences in substrate selectivity in Kex2 and furin protein convertases.

Holyoak T, Kettner CA, Petsko GA, Fuller RS, Ringe D.

Biochemistry. 2004 Mar 9;43(9):2412-21.

PMID:
14992578
21.

Electrophysiological analysis of the yeast V-type proton pump: variable coupling ratio and proton shunt.

Kettner C, Bertl A, Obermeyer G, Slayman C, Bihler H.

Biophys J. 2003 Dec;85(6):3730-8.

22.

2.4 A resolution crystal structure of the prototypical hormone-processing protease Kex2 in complex with an Ala-Lys-Arg boronic acid inhibitor.

Holyoak T, Wilson MA, Fenn TD, Kettner CA, Petsko GA, Fuller RS, Ringe D.

Biochemistry. 2003 Jun 10;42(22):6709-18.

PMID:
12779325
23.

Inhibition of the yeast V-type ATPase by cytosolic ADP.

Kettner C, Obermeyer G, Bertl A.

FEBS Lett. 2003 Jan 30;535(1-3):119-24.

24.

Inhibition of the bovine viral diarrhoea virus NS3 serine protease by a boron-modified peptidyl mimetic of its natural substrate.

Bukhtiyarova M, Rizzo CJ, Kettner CA, Korant BD, Scarnati HT, King RW.

Antivir Chem Chemother. 2001 Nov;12(6):367-73.

PMID:
12018682
25.

Hepatitis C virus NS3 protease requires its NS4A cofactor peptide for optimal binding of a boronic acid inhibitor as shown by NMR.

Archer SJ, Camac DM, Wu ZJ, Farrow NA, Domaille PJ, Wasserman ZR, Bukhtiyarova M, Rizzo C, Jagannathan S, Mersinger LJ, Kettner CA.

Chem Biol. 2002 Jan;9(1):79-92.

26.

Synthesis of boronic acid analogues of alpha-amino acids by introducing side chains as electrophiles.

Jagannathan S, Forsyth TP, Kettner CA.

J Org Chem. 2001 Sep 21;66(19):6375-80.

PMID:
11559189
27.

Drift ratchet

Kettner C, Reimann P, Hanggi P, Muller F.

Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 2000 Jan;61(1):312-23.

PMID:
11046268
28.

7-Azabicycloheptane carboxylic acid: a proline replacement in a boroarginine thrombin inhibitor.

Han W, Pelletier JC, Mersinger LJ, Kettner CA, Hodge CN.

Org Lett. 1999 Dec 16;1(12):1875-7.

PMID:
10836047
29.

Biochemical and crystallographic characterization of homologous non-peptidic thrombin inhibitors having alternate binding modes.

Strickland CL, Fevig JM, Galemmo RA Jr, Wells BL, Kettner CA, Weber PC.

Acta Crystallogr D Biol Crystallogr. 1998 Nov 1;54(Pt 6 Pt 2):1207-15.

PMID:
10089499
30.

Rational design of boropeptide thrombin inhibitors: beta, beta-dialkyl-phenethylglycine P2 analogs of DuP 714 with greater selectivity over complement factor I and an improved safety profile.

Fevig JM, Buriak J Jr, Cacciola J, Alexander RS, Kettner CA, Knabb RM, Pruitt JR, Weber PC, Wexler RR.

Bioorg Med Chem Lett. 1998 Feb 3;8(3):301-6.

PMID:
9871674
31.

Pyrazoles, 1,2,4-triazoles, and tetrazoles as surrogates for cis-amide bonds in boronate ester thrombin inhibitors.

Duncia JV, Santella JB 3rd, Higley CA, VanAtten MK, Weber PC, Alexander RS, Kettner CA, Pruitt JR, Liauw AY, Quan ML, Knabb RM, Wexler RR.

Bioorg Med Chem Lett. 1998 Apr 7;8(7):775-80.

PMID:
9871540
32.

Thrombin and human plasma kallikrein inhibition during simulated extracorporeal circulation block platelet and neutrophil activation.

Wachtfogel YT, Kettner C, Hack CE, Nuijens JH, Reilly TM, Knabb RM, Kucich U, Niewiarowski S, Edmunds LH Jr, Colman RW.

Thromb Haemost. 1998 Oct;80(4):686-91.

PMID:
9798991
33.

Electrophysiology in the eukaryotic model cell Saccharomyces cerevisiae.

Bertl A, Bihler H, Kettner C, Slayman CL.

Pflugers Arch. 1998 Nov;436(6):999-1013. Review.

PMID:
9799419
34.

Physiological characterization of the yeast plasma membrane outward rectifying K+ channel, DUK1 (TOK1), in situ.

Bertl A, Bihler H, Reid JD, Kettner C, Slayman CL.

J Membr Biol. 1998 Mar 1;162(1):67-80.

PMID:
9516239
35.

Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible rats.

Stadnicki A, Sartor RB, Janardham R, Majluf-Cruz A, Kettner CA, Adam AA, Colman RW.

FASEB J. 1998 Mar;12(3):325-33.

PMID:
9506476
36.
37.
38.

Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: modulation by a selective plasma kallikrein inhibitor.

Colman RW, Stadnicki A, Kettner CA, Adam AA, DeLa Cadena RA, Sartor RB.

Proc Assoc Am Physicians. 1997 Jan;109(1):10-22.

PMID:
9010912
39.

Cryptosporidium parvum metalloaminopeptidase inhibitors prevent in vitro excystation.

Okhuysen PC, Chappell CL, Kettner C, Sterling CR.

Antimicrob Agents Chemother. 1996 Dec;40(12):2781-4.

40.

Structure-based understanding of ligand affinity using human thrombin as a model system.

Nienaber VL, Mersinger LJ, Kettner CA.

Biochemistry. 1996 Jul 30;35(30):9690-9.

PMID:
8703940
41.

The contact system in experimental enterocolitis.

Stadnicki A, DeLa Cadena RA, Sartor RB, Kettner CA, Colman RW.

Immunopharmacology. 1996 Jun;33(1-3):314-6. No abstract available.

PMID:
8856173
42.

Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis rat.

Stadnicki A, DeLa Cadena RA, Sartor RB, Bender D, Kettner CA, Rath HC, Adam A, Colman RW.

Dig Dis Sci. 1996 May;41(5):912-20.

PMID:
8625762
43.

Possible new class of dense white dwarfs.

Glendenning NK, Kettner C, Weber F.

Phys Rev Lett. 1995 May 1;74(18):3519-3522. No abstract available.

PMID:
10058226
44.

Kinetic and crystallographic studies of thrombin with Ac-(D)Phe-Pro-boroArg-OH and its lysine, amidine, homolysine, and ornithine analogs.

Weber PC, Lee SL, Lewandowski FA, Schadt MC, Chang CW, Kettner CA.

Biochemistry. 1995 Mar 21;34(11):3750-7.

PMID:
7893672
45.

Inhibition of plasma kallikrein prevents peptidoglycan-induced arthritis in the Lewis rat.

Dela Cadena RA, Stadnicki A, Uknis AB, Sartor RB, Kettner CA, Adam A, Colman RW.

FASEB J. 1995 Mar;9(5):446-52.

PMID:
7896018
46.

Selective kallikrein inhibitors alter human neutrophil elastase release during extracorporeal circulation.

Wachtfogel YT, Hack CE, Nuijens JH, Kettner C, Reilly TM, Knabb RM, Bischoff R, Tschesche H, Wenzel H, Kucich U, et al.

Am J Physiol. 1995 Mar;268(3 Pt 2):H1352-7.

PMID:
7535008
47.

Structure and stability of strange and charm stars at finite temperatures.

Kettner C, Weber F, Weigel MK, Glendenning NK.

Phys Rev D Part Fields. 1995 Feb 15;51(4):1440-1457. No abstract available.

PMID:
10018612
48.

Nasal mucosal metabolism and absorption of pentapeptide enkephalin analogs having varying N-terminal amino acids.

Hussain MA, Seetharam R, Wilk RR, Aungst BJ, Kettner CA.

J Pharm Sci. 1995 Jan;84(1):62-4.

PMID:
7714746
49.

Intercomparison of spectral-UV-radiation measurement systems.

Seckmeyer G, Thiel S, Blumthaler M, Fabian P, Gerber S, Gugg-Helminger A, Häder DP, Huber M, Kettner C, Köhler U, Köpke P, Maier H, Schäfer J, Suppan P, Tamm E, Thomalla E.

Appl Opt. 1994 Nov 20;33(33):7805-12. doi: 10.1364/AO.33.007805.

PMID:
20962993

Supplemental Content

Loading ...
Support Center